Chunlei Li
State Key Laboratory Of Biotherapy/Collaborative Innovation Center For Biotherapy
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Retraction Note: SARI inhibits angiogenesis and tumour growth of human colon cancer through directly targeting ceruloplasmin.
Journal: Nature communications
Published: July 20, 2023
Corrigendum to "Anti-TNF-α monoclonal antibody reverses psoriasis through dual inhibition of inflammation and angiogenesis" [Int. Immunopharmacol. 28(1) (2015) 731-743].
Journal: International immunopharmacology
Published: November 13, 2020
Correction: IL-35 Decelerates the Inflammatory Process by Regulating Inflammatory Cytokine Secretion and M1/M2 Macrophage Ratio in Psoriasis.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: April 12, 2020
Erratum: Author Correction: A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity.
Journal: Signal transduction and targeted therapy
Published: October 25, 2019
A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity.
Journal: Signal transduction and targeted therapy
Published: September 02, 2016
IL-35 Decelerates the Inflammatory Process by Regulating Inflammatory Cytokine Secretion and M1/M2 Macrophage Ratio in Psoriasis.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 15, 2016
SARI inhibits angiogenesis and tumour growth of human colon cancer through directly targeting ceruloplasmin.
Journal: Nature communications
Published: October 06, 2015
Anti-TNF-α monoclonal antibody reverses psoriasis through dual inhibition of inflammation and angiogenesis.
Journal: International immunopharmacology
Published: April 08, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026